Yifeng Pharmacy Chain Co Ltd banner

Yifeng Pharmacy Chain Co Ltd
SSE:603939

Watchlist Manager
Yifeng Pharmacy Chain Co Ltd Logo
Yifeng Pharmacy Chain Co Ltd
SSE:603939
Watchlist
Price: 20.82 CNY -1.47% Market Closed
Market Cap: ¥25.2B

Wall St Price Targets

Price Targets Summary
Yifeng Pharmacy Chain Co Ltd

Wall Street analysts forecast Yifeng Pharmacy Chain Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Yifeng Pharmacy Chain Co Ltd is 34.74 CNY with a low forecast of 24.24 CNY and a high forecast of 45.44 CNY.

Lowest Forecast
Price Target
24.24 CNY
16% Upside
Average Forecast
Price Target
34.74 CNY
67% Upside
Highest Forecast
Price Target
45.44 CNY
118% Upside
Yifeng Pharmacy Chain Co Ltd Competitors:
Price Targets

Revenue
Forecast

24% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
24% / Year
Past Growth
16% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 12 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is 16%.

Gross Profit
Forecast

24% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
24% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 12 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 1 year is 25%.

Operating Income
Forecast

28% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
28% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 12 years, the compound annual growth rate for Operating Income has been 28%. The projected CAGR for the next 2 years is 29%.

Pre-Tax Income
Forecast

27% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
27% / Year
Past Growth
30% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 27%. The projected CAGR for the next 1 year is 30%.

Net Income
Forecast

27% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
27% / Year
Past Growth
33% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 12 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 1 year is 33%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is Yifeng Pharmacy Chain Co Ltd's stock price target?
Price Target
34.74 CNY

According to Wall Street analysts, the average 1-year price target for Yifeng Pharmacy Chain Co Ltd is 34.74 CNY with a low forecast of 24.24 CNY and a high forecast of 45.44 CNY.

What is the Revenue forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
16%

Over the last 12 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 2 years is 16%.

What is the Gross Profit forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
25%

Over the last 12 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 1 year is 25%.

What is the Operating Income forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
29%

Over the last 12 years, the compound annual growth rate for Operating Income has been 28%. The projected CAGR for the next 2 years is 29%.

What is the Pre-Tax Income forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
30%

Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 27%. The projected CAGR for the next 1 year is 30%.

What is the Net Income forecast for Yifeng Pharmacy Chain Co Ltd?
Projected CAGR
33%

Over the last 12 years, the compound annual growth rate for Net Income has been 27%. The projected CAGR for the next 1 year is 33%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett